Search research articles
Contact Us
Filters
Showing results (151-160 of 272) with videos related to
Page
of 28
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1991
Radiolabeled antibody therapy of human B cell lymphomas
O W Press, J F Eary, C C Badger, et al.
Blood
|
May 10, 2003
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911
Oliver W Press, Joseph M Unger, Rita M Braziel, et al.
Bioconjugate Chemistry
|
September 8, 2009
Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine
D Scott Wilbur, Monica S Thakar, Donald K Hamlin, et al.
Cancer Research
|
June 19, 2007
Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas
John M Pagel, Anastasia Pantelias, Nathan Hedin, et al.
Leukemia & Lymphoma
|
May 3, 2008
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma
Brian G Till, Theodore A Gooley, Nathan Crawford, et al.
Cancer Research
|
February 1, 1990
Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts
S A Ali, S D Warren, K Y Richter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody
O W Press, J F Eary, C C Badger, et al.
Lancet (London, England)
|
August 5, 1995
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas
O W Press, J F Eary, F R Appelbaum, et al.
The American Journal of Clinical Nutrition
|
July 1, 1983
Increased urinary excretion and prolonged turnover time of folic acid during ethanol ingestion
R M Russell, I H Rosenberg, P D Wilson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 12, 2010
Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulation
Scott E James, Philip D Greenberg, Michael C Jensen, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 272) with videos related to
Sort By:
Page
of 28
Advances in Experimental Medicine and Biology
|
January 1, 1991
Radiolabeled antibody therapy of human B cell lymphomas
O W Press, J F Eary, C C Badger, et al.
Blood
|
May 10, 2003
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911
Oliver W Press, Joseph M Unger, Rita M Braziel, et al.
Bioconjugate Chemistry
|
September 8, 2009
Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine
D Scott Wilbur, Monica S Thakar, Donald K Hamlin, et al.
Cancer Research
|
June 19, 2007
Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas
John M Pagel, Anastasia Pantelias, Nathan Hedin, et al.
Leukemia & Lymphoma
|
May 3, 2008
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma
Brian G Till, Theodore A Gooley, Nathan Crawford, et al.
Cancer Research
|
February 1, 1990
Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts
S A Ali, S D Warren, K Y Richter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody
O W Press, J F Eary, C C Badger, et al.
Lancet (London, England)
|
August 5, 1995
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas
O W Press, J F Eary, F R Appelbaum, et al.
The American Journal of Clinical Nutrition
|
July 1, 1983
Increased urinary excretion and prolonged turnover time of folic acid during ethanol ingestion
R M Russell, I H Rosenberg, P D Wilson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 12, 2010
Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulation
Scott E James, Philip D Greenberg, Michael C Jensen, et al.
Page
of 28